Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis - PubMed (original) (raw)
Comparative Study
. 1995 Oct;220(2):374-82.
doi: 10.1006/excr.1995.1328.
Affiliations
- PMID: 7556446
- DOI: 10.1006/excr.1995.1328
Comparative Study
Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis
M L Mello et al. Exp Cell Res. 1995 Oct.
Abstract
Changes in chromatin supraorganization defined in terms of patterns of chromatin texture were studied by video image analysis in Feulgen-stained revertants of LTR-ras-transformed NIH 3T3 cells and in cell lines obtained by transfection of these revertants with sense and antisense constructs of the lysyl oxidase gene (also named Lox or "ras recision gene"). The objective was to determine whether changes in expression of the Lox gene, which have been assumed to modulate cell transformation by ras, could also affect the chromatin supraorganization changes known to be elicited in NIH 3T3 cells by ras transformation. The image analysis results revealed that, although a nuclear phenotype visually similar to the most frequent one (III) in ras-transformed NIH 3T3 cells also appeared in the revertant, it contained a remarkably less tight chromatin packing state. This situation was also found in the revertant transfected with the sense construct of the Lox gene, but in the revertant transfected with the Lox antisense constructs the chromatin texture of the III phenotype was equal to or close to that of the ras-transformed cells. With regard to the nuclear phenotype characterized by abundant loosely packed chromatin and less represented in the transformed cell lines (I'), changes in the various cell lines, although detectable, were not as drastic as those reported for the III phenotype. The enhancement in chromatin condensation of the type III nuclei, which affects euchromatin, is probably associated with a limited transcription of the genome. Although the image analysis results are mostly in agreement with previously published data on the molecular biology and tumorigenicity of the same cell lines, it appears that the phenomenon of chromatin condensation once established in NIH 3T3 cells by LTR-ras transformation could not be totally reverted by simply affecting Lox expression.
Similar articles
- Nuclear changes induced in NIH/3T3 cells by transfection and tumorigenesis.
Mello ML, Russo J. Mello ML, et al. Cytobios. 1989;60(242-243):135-49. Cytobios. 1989. PMID: 2632149 - Scanning microphotometry image analysis of Ha-ras-transformed human breast epithelial cells.
Mello ML, Lin TY, Russo J. Mello ML, et al. Anal Cell Pathol. 1994 Dec;7(4):301-19. Anal Cell Pathol. 1994. PMID: 7696155 - Image analysis of Feulgen-stained NIH/3T3 cells transformed with DNA of 4-nitroquinoline 1-oxide treated human breast epithelial cells.
Mello ML, Vidal Bde C, Golembieski W, Russo J. Mello ML, et al. Biochem Cell Biol. 1992 Feb;70(2):109-16. doi: 10.1139/o92-016. Biochem Cell Biol. 1992. PMID: 1380816 - Transcriptional inhibition of Ha-ras in interferon-induced revertants of ras-transformed mouse cells.
Rimoldi D, Samid D, Flessate DM, Friedman RM. Rimoldi D, et al. Cancer Res. 1988 Sep 15;48(18):5157-62. Cancer Res. 1988. PMID: 2457435 - Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
Wu M, Min C, Wang X, Yu Z, Kirsch KH, Trackman PC, Sonenshein GE. Wu M, et al. Cancer Res. 2007 Jul 1;67(13):6278-85. doi: 10.1158/0008-5472.CAN-07-0776. Cancer Res. 2007. PMID: 17616686
Cited by
- The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1.
Schietke R, Warnecke C, Wacker I, Schödel J, Mole DR, Campean V, Amann K, Goppelt-Struebe M, Behrens J, Eckardt KU, Wiesener MS. Schietke R, et al. J Biol Chem. 2010 Feb 26;285(9):6658-69. doi: 10.1074/jbc.M109.042424. Epub 2009 Dec 21. J Biol Chem. 2010. PMID: 20026874 Free PMC article. - Cloning and characterization of a fourth human lysyl oxidase isoenzyme.
Mäki JM, Kivirikko KI. Mäki JM, et al. Biochem J. 2001 Apr 15;355(Pt 2):381-7. doi: 10.1042/0264-6021:3550381. Biochem J. 2001. PMID: 11284725 Free PMC article. - Localization and activity of lysyl oxidase within nuclei of fibrogenic cells.
Li W, Nellaiappan K, Strassmaier T, Graham L, Thomas KM, Kagan HM. Li W, et al. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12817-22. doi: 10.1073/pnas.94.24.12817. Proc Natl Acad Sci U S A. 1997. PMID: 9371758 Free PMC article. - NNK, a tobacco-specific carcinogen, inhibits the expression of lysyl oxidase, a tumor suppressor.
Cheng G, Li J, Zheng M, Zhao Y, Zhou J, Li W. Cheng G, et al. Int J Environ Res Public Health. 2014 Dec 23;12(1):64-82. doi: 10.3390/ijerph120100064. Int J Environ Res Public Health. 2014. PMID: 25546273 Free PMC article. - Lysyl oxidase, a critical intra- and extra-cellular target in the lung for cigarette smoke pathogenesis.
Li W, Zhou J, Chen L, Luo Z, Zhao Y. Li W, et al. Int J Environ Res Public Health. 2011 Jan;8(1):161-84. doi: 10.3390/ijerph8010161. Epub 2011 Jan 19. Int J Environ Res Public Health. 2011. PMID: 21318022 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources